VKTX - Viking Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VKTX is currently covered by 11 analysts with an average price target of $66.47. This is a potential upside of $38.04 (133.8%) from yesterday's end of day stock price of $28.43.

Viking Therapeutics's activity chart (see below) currently has 54 price targets and 97 ratings on display. The stock rating distribution of VKTX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 71.26% with an average time for these price targets to be met of 575.87 days.

Highest price target for VKTX is $138, Lowest price target is $71, average price target is $92.5.

Most recent stock forecast was given by STEVEN SEEDHOUSE from CANTOR FITZGERALD on 27-Apr-2025. First documented stock forecast 25-Mar-2018.

Currently out of the existing stock ratings of VKTX, 53 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$104

$76.45 (277.50%)

$125

19 days ago
(27-Apr-2025)

10/15 (66.67%)

$78.06 (300.93%)

620

Buy

$102

$74.45 (270.24%)

$102

23 days ago
(23-Apr-2025)

13/28 (46.43%)

$76.34 (297.51%)

795

Buy

$102

$74.45 (270.24%)

$105

23 days ago
(23-Apr-2025)

0/3 (0%)

$76.34 (297.51%)

Buy

$96

$68.45 (248.46%)

$109

3 months 10 days ago
(06-Feb-2025)

3/5 (60%)

$63.44 (194.84%)

1185

Buy

$71

$43.45 (157.71%)

$74

3 months 11 days ago
(05-Feb-2025)

0/2 (0%)

$39.54 (125.68%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VKTX (Viking Therapeutics) average time for price targets to be met?

On average it took 575.87 days on average for the stock forecasts to be realized with a an average price target met ratio 71.26

Which analyst has the current highest performing score on VKTX (Viking Therapeutics) with a proven track record?

JAMES LEE

Which analyst has the most public recommendations on VKTX (Viking Therapeutics)?

James Lee works at MIZUHO and has 27 price targets and 24 ratings on VKTX

Which analyst is the currently most bullish on VKTX (Viking Therapeutics)?

Jay Olson with highest potential upside - $110.45

Which analyst is the currently most reserved on VKTX (Viking Therapeutics)?

James Lee with lowest potential downside - -$42

Viking Therapeutics in the News

Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss of US$46 Million in Q1 2025

Viking Therapeutics has experienced a share price increase of 20% over the last month. This comes amidst the company’s report of increased financial losses, with a net loss of $46 million in Q1 2025, up from $27 million the previous year, and a change in their auditing firm from Marcum to CBIZ. While these company-specific...

1 Beaten-Down Stock to Buy and Hold for 10 Years

Key Points Viking Therapeutics’ shares have dropped this year for several reasons. However, not much has changed about its prospects since its stock price soared in 2024. Though it’s a somewhat risky bet, Viking could produce outsize returns in the next decade. Viking Therapeutics(NASDAQ: VKTX) was one of the hottest biotech stocks of 2024; its...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?